14.6.2024
13.6.2024
11
Jun
2024
12
14
Find more news and events
Suomeksi
In English
A new study from the University of Eastern Finland and the University of Tübingen helps to explain what defines how long a drug molecule stays bound to its target.
Regular physical activity significantly changes the body’s metabolite profile, and many of these changes are associated with a lower risk of type 2 diabetes, a new study shows.
Most of the disease-modifying antirheumatic drugs were not associated with the risk of Parkinson's disease, a new register-based study shows. An exception was the use of chloroquine or hydroxychloroquine which associated with a lower risk.
Arterial stiffness may be a novel risk factor to be targeted in the prevention and treatment of insulin resistance and dyslipidaemia from a young age, a new study suggests.
“Coronary artery disease has, for a long time, been mainly treated with cholesterol-lowering drugs, but there is a need for other types of treatments as well. For example, new drugs could target pathogenic changes taking place in the arterial wall,” Professor Minna Kaikkonen-Määttä says.
The FIND trial found that taking a much higher dose of vitamin D than recommended for five years did not affect total mortality or the incidence of cardiovascular disease or cancer in older men and women.
A new study discovered differences in one-carbon and energy metabolism between episodic and chronic depression. One-carbon metabolism plays a key role in the production of, e.g., neurotransmitters.
Changes in grain consumption and novel cereal protein-enriched food innovations could play a major role in transitioning towards a more sustainable food system for healthy diets, according to Nordic researchers.
Type 2 diabetes is often accompanied by elevated cholesterol levels, but many patients do not receive appropriate cholesterol-lowering treatment.
Arterial stiffness is a novel risk factor to be targeted for preventing and treating hypertension and obesity from a young age, a new study suggests.